Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 21
Filter
1.
Ann Thorac Cardiovasc Surg ; 20(2): 169-72, 2014.
Article in English | MEDLINE | ID: mdl-23269271

ABSTRACT

INTRODUCTION: Popliteal artery entrapment syndrome (PAES) is the rare congenital abnormality. It is a threat to the lower extremity due to ischemia in young adults. CASE REPORT: A 32-year-old health worker (medical doctor) applied to our clinic with a complaint of lower extremity pain, paleness, and coldness, post-exercise. He did not have any complaint to make him think as ischemia. Peripheral arterial angiography was applied, but the main diagnosis was given by magnetic resonance imaging angiography. Medical thrombolytic treatment, femoral embolectomy and then tendon resection, approached posteriorly, were applied to the popliteal region. DISCUSSION: Repeated exterior microtraumas cause thickening in the arterial wall, early atherosclerosis, thrombus and ischemia. To diagnose this entity is difficult. Treatment should be surgical, oriented to abolish the compression. CONCLUSION: In this case, we wanted to emphasize how quiet the progression of the PAES may be, and effacement of the compression is essential in the treatment. Femoral embolectomy does not have any aid to treatment.


Subject(s)
Arterial Occlusive Diseases/surgery , Blood Vessel Prosthesis Implantation , Decompression, Surgical/methods , Popliteal Artery/surgery , Tendons/surgery , Adult , Arterial Occlusive Diseases/diagnosis , Arterial Occlusive Diseases/physiopathology , Collateral Circulation , Disease Progression , Embolectomy , Humans , Magnetic Resonance Angiography , Male , Popliteal Artery/diagnostic imaging , Popliteal Artery/physiopathology , Radiography , Regional Blood Flow , Thrombolytic Therapy , Treatment Outcome
2.
Gen Thorac Cardiovasc Surg ; 56(11): 563-5, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19002758

ABSTRACT

Weaning from cardiopulmonary bypass is the most important stage during mitral valve surgery, especially in patients with severe pulmonary hypertension. We report two patients with severe pulmonary hypertension who were operated on because of valvular heart disease. To reduce the pulmonary artery pressure, levosimendan was used because of its vasodilatory and cytoprotective effects. All patients tolerated the operation and levosimendan administration. Their postoperative course was uneventful. Levosimendan can be used to treat pulmonary hypertension during operations for heart valve disease. Patients clearly benefit from the vasodilator action of the drug for reducing pulmonary artery pressure.


Subject(s)
Cardiac Surgical Procedures , Heart Valve Diseases/surgery , Hydrazones/therapeutic use , Hypertension, Pulmonary/drug therapy , Pyridazines/therapeutic use , Vasodilator Agents/therapeutic use , Female , Follow-Up Studies , Heart Valve Prosthesis Implantation , Humans , Hydrazones/administration & dosage , Middle Aged , Pyridazines/administration & dosage , Simendan , Time Factors , Treatment Outcome , Vasodilator Agents/administration & dosage
3.
J Card Surg ; 23(3): 251-3, 2008.
Article in English | MEDLINE | ID: mdl-18435642

ABSTRACT

BACKGROUND AND AIM: Postoperative neurologic deficit is the most devastating complication after surgical thoracic aorta repair. Cerebrospinal fluid drainage and some medications are used for spinal cord protection during and after the operation. METHODS: A 25-year-old patient applied to our clinic with a traumatic descending aortic aneurysm. We performed a surgical repair for the aneurysm but could not achieve to place a lumbar catheter to provide cerebrospinal fluid drainage. Levosimendan was chosen for spinal cord ischemic preconditioning because of its vasodilatory effects. RESULTS: Postoperative course was uneventful. Hemodynamic and neurologic complication was not observed, and the patient was discharged from the hospital in the postoperative 5th day. CONCLUSIONS: Levosimendan can be used for preconditioning and spinal cord protection from ischemic injury during descending aorta repair. We clearly benefit from the vasodilator peculiarity of the drug for improving spinal cord perfusion.


Subject(s)
Aortic Aneurysm, Thoracic/surgery , Hydrazones/therapeutic use , Ischemic Preconditioning/methods , Pyridazines/therapeutic use , Spinal Cord/blood supply , Vasodilator Agents/therapeutic use , Adult , Humans , Male , Simendan , Spinal Cord Ischemia/prevention & control
4.
J Card Surg ; 23(2): 107-13, 2008.
Article in English | MEDLINE | ID: mdl-18304123

ABSTRACT

BACKGROUND: Comparison of neurological parameters in patients undergoing prosthetic heart valve replacement with two operating techniques-either cardioplegic arrest of the heart under hypothermic cardiopulmonary bypass (CPB) or the heart beating on normothermic bypass, with or without cross-clamping the aorta, without cardioplegic arrest. methods: Fifty valvular surgery patients were randomly assigned into three groups. Sixteen patients underwent beating heart valve replacement with normothermic bypass without cross-clamping the aorta, 17 patients underwent the same procedure with cross-clamping the aorta and retrograde coronary sinus perfusion, and the remaining 17 patients had conventional surgery with hypothermic bypass and cardioplegic arrest. RESULTS: Two-channel electroencephalography (EEG) was recorded to assess changes in cerebral cortical synaptic activity and 95% spectral edge frequency values were recorded continuously. Bispectral monitoring was used to measure the depth of anesthesia. Blood flow rates in middle cerebral artery (MCA) were measured by transcranial Doppler (TCD). Reduction in spectral edge frequency (>50%) or bispectral index (BIS) (<20) or transcranial Doppler flow velocity (>50%) was detected in four patients in Group 1, five patients in Group 2, and three patients in Group 3. BIS or EEG values never reached zero, which indicates isoelectric silence during surgery. Gross neurological examinations were normal in all patients postoperatively. CONCLUSION: There is no difference regarding neurological monitoring results between on-pump beating heart and hypothermic arrested heart valve replacement surgery. Also no significant difference was encountered among the groups regarding the clinical outcomes.


Subject(s)
Aortic Valve/surgery , Cardiopulmonary Bypass , Heart Valve Prosthesis Implantation/methods , Hypothermia, Induced , Mitral Valve/surgery , Adult , Blood Flow Velocity , Brain Ischemia/etiology , Electrocardiography , Female , Health Status Indicators , Heart Valve Prosthesis Implantation/adverse effects , Humans , Male , Middle Cerebral Artery , Prospective Studies , Treatment Outcome
5.
J Card Surg ; 23(2): 156-8, 2008.
Article in English | MEDLINE | ID: mdl-18304132

ABSTRACT

BACKGROUND AND AIM: Conventional mitral valve replacement (MVR) is carried out under cardioplegic arrest with cross-clamping of the ascending aorta during cardiopulmonary bypass. In this case, MVR was performed with on-pump beating heart technique without cross-clamping the aorta because of the diffuse adhesion around the ascending aorta, and tube graft presence between ascending and descending aortas. METHODS: A 47-year-old female patient had aorto-aortic bypass graft from ascending aorta to descending aorta with median sternotomy and left thoracotomy in single stage because of aortic coarctation 2 years ago in our cardiac center. She was admitted to the hospital with palpitation and dyspnea on mild exertion. Transthoracic echocardiography revealed 4th degree mitral insufficiency. RESULTS: MVR was carried out through remedian sternotomy with on-pump beating heart technique without cross-clamping the aorta. CONCLUSIONS: MVR with on-pump beating heart technique offers a safe approach when excessive dissection is required to place cross-clamp on the ascending aorta.


Subject(s)
Aorta, Thoracic/surgery , Aorta/surgery , Aortic Coarctation/surgery , Cardiopulmonary Bypass/methods , Coronary Artery Bypass/methods , Heart Valve Prosthesis Implantation/methods , Mitral Valve Insufficiency/surgery , Mitral Valve/surgery , Dyspnea , Female , Humans , Middle Aged , Mitral Valve/pathology
6.
J Card Surg ; 23(2): 159-62, 2008.
Article in English | MEDLINE | ID: mdl-18304133

ABSTRACT

The internal thoracic artery (ITA) is the gold-standard conduit for coronary artery bypass surgery. It stays patent well in the long-term period, and this evidence is directly related to the superior later outcome in terms of longevity. Coronary artery bypass grafting with multiarterial grafts can be performed safely, and better long-term result can be expected with the use of arterial conduits, especially ITA. We describe a simple and practical technique for the left ITA grafting by dividing the ITA graft and using its proximal and distal parts in situ for the distal left anterior descending (LAD) artery and the obtuse marginal artery grafting.


Subject(s)
Coronary Artery Bypass/methods , Mammary Arteries/surgery , Cardiovascular Surgical Procedures/methods , Coronary Stenosis/diagnostic imaging , Coronary Stenosis/surgery , Humans , Radial Artery/surgery , Treatment Outcome , Ultrasonography
7.
J Card Surg ; 23(1): 44-8, 2008.
Article in English | MEDLINE | ID: mdl-18290886

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: The new calcium sensitizer, levosimendan, not only acts as a positive inotropic agent but also, vasodilates both venules and arterioles. The aim of this experimental study was to investigate whether levosimendan has protective effects on spinal cord ischemia-reperfusion injury. MATERIAL AND METHODS: Twelve New Zealand rabbits were enrolled in this study. In addition to the control group, levosimendan is administered to the experimental group with a loading dose of 12 microg/kg prior to ischemia over a 10-minute period, followed by an infusion of 0.2 microg/kg/min during the ischemia period (30-minutes). Following the neurologic evaluation at the 24th hour of reperfusion, lumbar spinal cords were removed in order to perform microscopic examination and malondialdehyde (MDA) and myeloperoxidase (MPO) measurements. RESULTS: The mean Tarlov score of the levosimendan group (3.25) was higher than the control group (0.7) (p< 0.05). MDA level was found significantly lower in the levosimendan group when compared with the control group as 1.6 +/- 0.4 nmol/gr and 189.3 +/- 43.6 nmol/gr respectively (p < 0.05). MPO level was also found statistically significant when we compared levosimendan group with the control group. It was calculated as 11.3 +/- 1.0 micro/gr tissue and 39.1 +/- 16.9 micro/gr in the levosimendan and the control groups (p< 0.05). Light microscopic examination was carried out with tissue samples in the 24th hour of the reperfusion. Levosimendan group had better preservation with the microscopic appearance with respect to the control group. CONCLUSION: Levosimendan exhibits an important protection by means of neurological outcome, histopathological, and biochemical analysis for the ischemia-reperfusion injury of the spinal cord following the aortic clamping.


Subject(s)
Hydrazones/pharmacology , Pyridazines/pharmacology , Reperfusion Injury/drug therapy , Spinal Cord Ischemia/drug therapy , Vasodilator Agents/pharmacology , Animals , Aorta , Constriction , Disease Models, Animal , Malondialdehyde/metabolism , Models, Cardiovascular , Peroxidase/metabolism , Rabbits , Random Allocation , Reperfusion Injury/metabolism , Reperfusion Injury/pathology , Research Design , Simendan , Single-Blind Method , Spinal Cord Ischemia/metabolism , Spinal Cord Ischemia/pathology , Statistics, Nonparametric , Treatment Outcome
9.
Ulus Travma Acil Cerrahi Derg ; 13(2): 135-41, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17682956

ABSTRACT

BACKGROUND: This study was planned to evaluate patients with penetrating cardiac injury. METHODS: Twenty-two patients had cardiac injury among twenty-five patients who had been referred to our hospital with a suspicion of this diagnosis. Data of the patients were retrospectively evaluated. RESULTS: Echocardiography could be performed in 11 patients with stable haemodynamics and pericardial effusion was established in all of them with one false positive result. The patient with false positive result had left internal thoracic artery and venous injury. Cardiac tamponade was seen in 17 (77%) patients. Injury sites were right ventricle 10 (45.5%), left ventricle 7 (31.8%), left ventricle consisting left anterior descending artery 2 (9.1%), right atrium 1 (4.5%) and pericardial injuries and hematoma 2 (9.1%). The mean physiologic index (PI) of the patients was 10.68+/-5.63, penetrating cardiac trauma index was (PCTI) 14.09+/-6.3, penetrating thoracic trauma index (PTTI) was 17+/-8.84 and organ injury scale according to the American Association for the Surgery of Trauma (AAST/OIS) was 3.86+/-1.25. Mortality rate was 27.3% with 6 out of 22 patients. PI, PCTI, PTTI and AAST/OIS scores of the non-survivors were significantly higher than those of the survivors (p<0.05). While there was no difference between survivors and non-survivors regarding the presence of tamponade and the frequency of the associated abdominal injury, left ventricular and left anterior descending artery injuries and associated lung injuries were more common in non-survivors (p<0.05). CONCLUSION: Non-survivors with penetrating cardiac injury have higher PI, PCTI, PTTI and AAST/OIS scores and they are more severely injured patients comparing to the survivors.


Subject(s)
Heart Injuries/epidemiology , Wounds, Penetrating/epidemiology , Adolescent , Adult , Aged , Child , Echocardiography , Emergency Treatment , Female , Heart Injuries/diagnostic imaging , Heart Injuries/etiology , Heart Injuries/mortality , Heart Injuries/pathology , Heart Injuries/surgery , Humans , Injury Severity Score , Male , Medical Records , Middle Aged , Retrospective Studies , Thoracic Surgical Procedures , Turkey/epidemiology , Wounds, Penetrating/diagnostic imaging , Wounds, Penetrating/etiology , Wounds, Penetrating/mortality , Wounds, Penetrating/pathology , Wounds, Penetrating/surgery
10.
Anadolu Kardiyol Derg ; 7(2): 158-63, 2007 Jun.
Article in English | MEDLINE | ID: mdl-17513212

ABSTRACT

OBJECTIVE: The study aim was to investigate the effect of blood glucose level on atherosclerotic lesion distribution and the contribution to the operative mortality/morbidity in diabetic patients who underwent coronary artery bypass grafting (CABG). METHODS: Between 1986-2003, a total of 2095 patients with diabetes mellitus underwent CABG. The analysis was carried out retrospectively from the clinical records. The patients were divided into four groups according to the blood glucose levels that were obtained when they first applied to hospital; Group 1 (492 patients with blood glucose < 120 mg/dl), group 2 (1112 patients with blood glucose - 120-200 mg/dl, group 3 (261 patients with blood glucose 201-250 mg/dl) and group 4 (230 patients with blood glucose > 250 mg/dl). One way ANOVA test was used for the statistical analysis of continuous variables and Chi-square test was used for analyzing the categorical variables. RESULTS: Emergent operation rate due to acute ischemia gradually increased from Group 1 to Group 4 and reached 6.6% in Group 4 (p=0.005). Operation time and the duration of cardiopulmonary bypass and cross clamp were significantly longer in patients with high blood glucose levels (p<0.05). Necessity for inotropic drug administration postoperatively (p<0.05) and mechanical support (p<0.05) were significantly higher also. The hospital mortality in group 3 was 9.6% and in group 4 was 11.3% (p=0.09). No statistically significant difference was found in terms of morbidity between the groups (p>0.05). The multi-vessel coronary artery disease was more common in groups with high blood glucose level (p<0.05). As the blood glucose level raised, patients were more frequently (p<0.05) confronted with distal left anterior descending artery, middle circumflex artery and right coronary artery lesions. CONCLUSION: Uncontrolled blood glucose level not only increased the perioperative complications but also the incidence of middle and distal coronary artery lesions. It is necessary to diagnose and aggressively treat the high blood glucose level especially before the CABG.


Subject(s)
Blood Glucose , Coronary Artery Bypass , Coronary Artery Disease/epidemiology , Coronary Artery Disease/surgery , Diabetes Mellitus , Coronary Artery Disease/blood , Coronary Artery Disease/mortality , Coronary Artery Disease/pathology , Female , Humans , Intraoperative Complications , Male , Medical Records , Middle Aged , Postoperative Complications , Retrospective Studies , Risk Factors , Severity of Illness Index , Treatment Outcome , Turkey/epidemiology
11.
Ann Vasc Surg ; 21(3): 360-6, 2007 May.
Article in English | MEDLINE | ID: mdl-17484972

ABSTRACT

The periods of ischemia and reperfusion represent different characteristics by lack of oxygen and reoxygenation. The aim of this experimental spinal cord injury model was to investigate whether resveratrol has protective effects during ischemia or reperfusion and the mechanism of the protection by using N-nitro-L-arginine methyl ester (L-NAME), an inhibitor of nitric oxide synthase. Rabbits were divided into seven groups according to the time of administration of resveratrol or L-NAME (RI and RR, resveratrol during ischemia or reperfusion; IL and RL, L-NAME during ischemia or reperfusion; RILR, resveratrol during ischemia and L-NAME during reperfusion; LIRR, L-NAME during ischemia and resveratrol during reperfusion; control group). After neurologic evaluation at the twenty-fourth hour of reperfusion, lumbar spinal cords were removed for electron microscopic evaluation, immunohistochemical staining for apoptosis, and malondialdehyde (MDA) and myeloperoxidase (MPO) measurements. The RILR group had the best functional recovery, with a mean 3.6 Tarlov score (P < 0.05), and showed near normal electron microscopic findings (scores of 7.6 +/- 0.9 for the control group and 3.9 +/- 2.9 for the RILR group, P < 0.05). MPO and MDA levels were decreased in all groups compared with the control group, but only the decrement in the RILR group reached statistical significance. Immunohistochemical analysis showed that the groups including resveratrol and L-NAME together had the best staining for apoptosis. Resveratrol exhibits important protection by means of neurologic outcome, histopathologic analysis, and biochemical analysis, especially when used in during ischemia followed by L-NAME administration during reperfusion. Also, resveratrol protects against apoptosis, especially when combined with L-NAME.


Subject(s)
Antioxidants/pharmacology , Ischemic Preconditioning/adverse effects , Lumbar Vertebrae/blood supply , Reperfusion Injury/etiology , Reperfusion Injury/prevention & control , Reperfusion/adverse effects , Stilbenes/pharmacology , Analysis of Variance , Animals , Apoptosis/drug effects , Disease Models, Animal , Enzyme Inhibitors/pharmacology , Hindlimb/physiopathology , Immunohistochemistry , Lumbar Vertebrae/drug effects , Lumbar Vertebrae/physiopathology , Malondialdehyde/metabolism , Microscopy, Electron , Movement/drug effects , NG-Nitroarginine Methyl Ester/pharmacology , Nitrates/blood , Nitrites/blood , Peroxidase/drug effects , Peroxidase/metabolism , Rabbits , Recovery of Function/drug effects , Reperfusion Injury/physiopathology , Resveratrol , Spinal Cord Injuries/etiology , Spinal Cord Injuries/prevention & control , Time Factors , Treatment Outcome
12.
J Card Surg ; 22(2): 135-6, 2007.
Article in English | MEDLINE | ID: mdl-17338747

ABSTRACT

A 60-year-old man with a history of a prior double-valve replacement (DVR) and permanent pacemaker implantation underwent mitral valve reoperation due to a paravalvular leak. Reoperation was performed on a beating heart (BH) on cardiopulmonary bypass, by perfusing the heart continuously with oxygenated noncardioplegic normothermic blood via the coronary sinus. We report the case of a patient who underwent mitral valve reoperation on a beating heart, 10 years after his first double-valve replacement and permanent pacemaker implantation.


Subject(s)
Heart Valve Prosthesis Implantation/methods , Mitral Valve Insufficiency/surgery , Pacemaker, Artificial , Atrial Fibrillation/therapy , Cardiopulmonary Bypass/methods , Extracorporeal Membrane Oxygenation , Heart Failure/therapy , Humans , Male , Middle Aged , Reoperation
13.
Heart Lung Circ ; 15(5): 320-4, 2006 Oct.
Article in English | MEDLINE | ID: mdl-16860605

ABSTRACT

BACKGROUND: Although cathecholamines are well-established agents of myocardial support during weaning from cardiopulmonary bypass (CPB), there has been little experience with a new inotropic agent, levosimendan. Our aim was to present our experience with levosimendan usage in patients manifesting failure-to-wean from CPB after coronary artery bypass grafting (CABG) when conventional inotropic and intraaortic balloon counterpulsation (IABP) therapies proved to be insufficient. METHODS: Fifteen patients undergoing CABG received levosimendan as a loading dose of 12-24 microg/kg over 10 min, followed by a continuous infusion of 0.1-0.2 microg/(kg min) for 24h. Hemodynamic measurements were performed at baseline and at 1, 24 and 48 h postoperatively. RESULTS: Mean patient age was 63.2+/-2.2 years. CPB time was 149.7+/-19.5 min, while cross-clamp time was 67.8+/-10.5 min. All patients showed evidence of hemodynamic improvement with the start of levosimendan infusion and 14 patients (93.3%) were successfully weaned from CPB. Eight patients (53.3%) experienced significant increases in cardiac index and blood pressure leading to a lessening of the need for catecholamine support. Five patients (33.3%) were lost postoperatively in the ICU. CONCLUSION: Levosimendan appears to be useful in failure-to-wean from CPB after cardiotomy when conventional inotropic therapy proves inadequate.


Subject(s)
Cardiopulmonary Bypass , Cardiotonic Agents/administration & dosage , Coronary Artery Bypass/methods , Coronary Disease/surgery , Hydrazones/administration & dosage , Postoperative Care/methods , Pyridazines/administration & dosage , Ventilator Weaning/methods , Aged , Blood Pressure/drug effects , Coronary Disease/physiopathology , Female , Follow-Up Studies , Humans , Infusions, Intravenous , Male , Middle Aged , Simendan , Stroke Volume/drug effects , Treatment Outcome
14.
J Thorac Cardiovasc Surg ; 128(3): 354-6, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15354091

ABSTRACT

BACKGROUND: This study was conceived to evaluate the effect of carbon dioxide insufflation on free internal thoracic artery flows. METHODS: We studied 56 consecutive patients who underwent coronary artery bypass grafting in which the left internal thoracic artery was anastomosed to the left anterior descending artery. The first 26 consecutive internal thoracic arteries were harvested as a pedicled graft (group 1), and the next 30 consecutive internal thoracic arteries were dissected by using the carbon dioxide insufflation technique (group 2). The internal thoracic artery harvesting was performed by 2 experienced surgeons by using the same instrumentation and technique. First, free flows of the internal thoracic arteries were registered after distal cutting of the vessel in both groups. After the first measurements, diluted papaverine was sprayed on the internal thoracic artery pedicle only in group 1, and then second measurements were registered after 15 minutes in both groups. Hemodynamic parameters were recorded with each measurement. RESULTS: The first free flow measurement was significantly higher in the carbon dioxide-insufflated internal thoracic arteries (group 2, 60 +/- 32 mL/min; group 1, 28 +/- 19 mL/min; P <.05). Although the second free flow measurement of the carbon dioxide-insufflated group was higher than in group 1, the difference was not statistically significant (68 +/- 46 mL/min vs 53 +/- 32 mL/min; P =.53). CONCLUSIONS: Carbon dioxide insufflation of the internal thoracic artery is an efficient technique to increase the flow and seems to be safe, simple, and reliable. When the internal thoracic artery is harvested in a carbon dioxide-insufflated fashion, arterial spasm and reduced early flow may be avoided, even without vasodilator agents such as papaverine.


Subject(s)
Carbon Dioxide/pharmacology , Thoracic Arteries/drug effects , Thoracic Arteries/physiology , Vasodilator Agents/pharmacology , Female , Humans , Insufflation , Male , Middle Aged , Regional Blood Flow/drug effects
15.
J Heart Valve Dis ; 13(4): 641-50, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15311873

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: Recent data regarding the performance of mechanical prostheses in patients aged > or =65 years are scant. Hence, the outcome of mechanical prosthesis implantation in this age group has been retrospectively evaluated. METHODS: Between January 1990 and October 2002, 253 patients (163 males, 90 females) aged > or =65 years (mean age 68.2 years) underwent aortic valve replacement (AVR) and/or mitral valve replacement (MVR) at the authors' institution. RESULTS: Among the patients, 94 (37.2%) had MVR, 137 (54.1%) had AVR, and 22 (8.7%) had MVR+AVR. In total, 99 patients (39.1%) had concomitant coronary artery bypass grafting (CABG). The early mortality rate was 11.1%; that for patients aged > or =70 years was greater than that for patients aged 65-69 years (14.5% versus 9.6%, p <0.001). The overall actuarial survival was 91.3 +/- 2.4% at 5 years, 81.1 +/- 4.1% at 8 years, and 73.8 +/- 6.3% at 10 years. Actuarial survival for patients with isolated AVR and MVR at 10 years was 84.7 +/- 6.0% and 61.4 +/- 18.8%, respectively. Actuarial survival at 10 years for patients with isolated valve replacement was 76.1 +/- 8.1%, and 68.7 +/- 10.2% for patients with concomitant CABG (p = 0.680). Actuarial survival at 10 years was 81.3 +/- 6.9% for patients aged 65-69 years, and 50.3 +/- 11.0% for patients aged > or =70 years (p = 0.001). Freedom from a major thromboembolic event was 99.4 +/- 0.7% at five years and 86.3 +/- 6.0% at 10 years, while freedom from hemorrhage was 90.4 +/- 2.6% and 70.3 +/- 6.8%, respectively. CONCLUSION: Mechanical prostheses can be used in patients aged > or =65 years, with favorable results. However, on the basis of the present findings, patients aged > or =70 years have a reduced early and late survival.


Subject(s)
Aortic Valve Insufficiency/surgery , Aortic Valve Stenosis/surgery , Aortic Valve/pathology , Aortic Valve/surgery , Heart Valve Prosthesis Implantation , Heart Valve Prosthesis , Mitral Valve Insufficiency/surgery , Mitral Valve Stenosis/surgery , Mitral Valve/pathology , Mitral Valve/surgery , Aged , Aortic Valve Insufficiency/mortality , Aortic Valve Stenosis/mortality , Combined Modality Therapy , Coronary Artery Bypass , Coronary Artery Disease/mortality , Coronary Artery Disease/surgery , Female , Follow-Up Studies , Hospital Mortality , Humans , Length of Stay , Male , Mitral Valve Insufficiency/mortality , Mitral Valve Stenosis/mortality , Postoperative Complications/etiology , Postoperative Complications/mortality , Retrospective Studies , Survival Analysis , Time Factors , Treatment Outcome , Turkey
16.
J Heart Valve Dis ; 13(1): 33-7, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14765837

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: Angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphism, angiotensinogen (AGT) gene polymorphism and angiotensin II type 1 receptor (AT1R) polymorphism in relation to rheumatic mitral valve disease were examined in a case-control study to investigate possible relationships between these gene polymorphisms and rheumatic mitral valve disease in patients undergoing mitral valve replacement (MVR). METHODS: A total of 50 patients with rheumatic mitral valve disease and undergoing MVR was compared with 50 normal, and age- and sex-matched control subjects. ACE I/D, AGT gene M235T and AT1R-adenine/cytosine 1166 (A1166C) genotype polymorphisms were identified by polymerase chain reaction (PCR) -based restriction analysis. RESULTS: ACE I/D polymorphism differed significantly between the groups. The control group mostly represented the heterozygote ID allele (74%), while the MVR group showed frequencies of 60% for the homozygote DD and II alleles. MM homozygote frequency was significantly greater in controls, but TT homozygote frequency was significantly greater in the MVR group. AT1R-A1166C genotype polymorphism also differed significantly between groups; the MVR group had 73.7% of the AC heterozygote allele, while controls had 64.4% of the AA and 66.7% of the CC homozygote alleles. CONCLUSION: These results provided evidence of an association between ACE I/D polymorphism, M235T polymorphism and AT1R-A1166C genotype polymorphism and rheumatic mitral valve disease.


Subject(s)
Mitral Valve , Polymorphism, Genetic , Renin-Angiotensin System/genetics , Rheumatic Heart Disease/genetics , Adult , Female , Humans , Male , Middle Aged
17.
Eur Surg Res ; 36(1): 20-5, 2004.
Article in English | MEDLINE | ID: mdl-14730219

ABSTRACT

OBJECTIVES: To evaluate the effects of intravenous magnesium sulfate (Mg(2)SO(4)) administration on ischemia-reperfusion injury of the spinal cord. MATERIAL AND METHODS: Sixteen rabbits were randomly assigned to the control (group I, 8 rabbits) and the study group (group II, 8 rabbits). The abdominal aorta was clamped for a period of 30 min followed by a reperfusion period of 60 min. The animals in group II received 0.25 ml/kg/h Mg(2)SO(4) intravenous infusion (15% Mg(2)SO(4)) throughout this procedure. The animals were then observed for 24 h after which their neurological states were evaluated and tissue samples obtained from the spinal cord were examined with electron microscopy. RESULTS: Aortic pressure distal to the cross-clamp during the occlusion period was 9 +/- 3 mm Hg in group I and 19 +/- 6 mm Hg in group II. All animals in group I were paraplegic at the end of the study. In group II the neurological outcome of 1 animal was poor while the other 7 animals were neurologically in a good condition. Electron microscopic examinations of the spinal cord tissues of group I revealed severe injury but the ultrastructure was well preserved in group II. CONCLUSIONS: Intravenous Mg(2)SO(4) administration may have protective effects on the ischemia-reperfusion injury of the spinal cord. We propose that Mg(2)SO(4) may be an additional protective pharmacological agent in thoracal and thoracoabdominal aortic surgery.


Subject(s)
Magnesium Sulfate/pharmacology , Neuroprotective Agents/pharmacology , Reperfusion Injury/pathology , Spinal Cord Ischemia/pathology , Animals , Aorta/physiopathology , Blood Pressure , Injections, Intravenous , Magnesium Sulfate/administration & dosage , Microscopy, Electron , Nervous System/physiopathology , Neuroprotective Agents/administration & dosage , Paraplegia/etiology , Rabbits , Reperfusion Injury/complications , Reperfusion Injury/physiopathology , Spinal Cord/pathology , Spinal Cord/physiopathology , Spinal Cord/ultrastructure , Spinal Cord Ischemia/complications , Spinal Cord Ischemia/physiopathology
18.
J Heart Valve Dis ; 12(5): 585-91, 2003 Sep.
Article in English | MEDLINE | ID: mdl-14565711

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: The study aim was to investigate the long-term efficacy of closed mitral valvotomy (CMV). METHODS: Data obtained over a 36-year period from 1,134 patients who underwent CMV were analyzed. The analysis was carried out retrospectively from hospital records, with follow up examinations being conducted mainly at the outpatient clinic. RESULTS: In-hospital mortality (< or = 30 days after surgery) was 0.4% (n = 5, all closed procedures). Cardiac failure was the main cause of early death, and postoperative peripheral embolism occurred in five cases (0.5%). Freedom from thromboembolism was 99.0 +/- 0.5% at 36 years. Operative results were satisfactory in most patients, and severe mitral incompetence was seen only in three cases. Post-valvotomy mitral regurgitation occurred in 88 patients (7.7%) during the first year after CMV. Reoperation was performed in 500 patients (44.1%). The mean interval between CMV and reoperation was 141.1 +/- 80.8 months (range: 1-436 months). Fourteen patients were reoperated on for mitral regurgitation, 485 for mitral restenosis, and five for mixed mitral valve disease (stenosis and regurgitation). Freedom from reoperation after CMV was 81.4 +/- 1.3% at 10 years, 16.4 +/- 2.1% at 20 years, 3.1 +/- 1.2% at 20 years, and 0% at 36 years. Cox regression analysis indicated that impaired functional capacity, reduced mitral valve area, gradual increase in left atrial diameter and postoperative mitral insufficiency increased the reoperation rate after CMV. CONCLUSION: When compared with percutaneous balloon or surgical open valvotomy, CMV represents a satisfactory technique in terms of simplicity, high efficacy and lower cost.


Subject(s)
Cardiac Surgical Procedures/trends , Catheterization/trends , Mitral Valve Stenosis/surgery , Adolescent , Adult , Cause of Death , Child , Disease-Free Survival , Echocardiography , Female , Follow-Up Studies , Heart Failure/etiology , Heart Failure/mortality , Heart Failure/surgery , Heart Valve Prosthesis Implantation/trends , Hospital Mortality , Humans , Male , Middle Aged , Mitral Valve Insufficiency/etiology , Mitral Valve Insufficiency/mortality , Mitral Valve Insufficiency/surgery , Mitral Valve Stenosis/mortality , Mitral Valve Stenosis/physiopathology , Patient Satisfaction , Postoperative Complications/etiology , Postoperative Complications/mortality , Postoperative Complications/surgery , Reoperation , Severity of Illness Index , Stroke Volume/physiology , Time , Time Factors , Treatment Outcome , Turkey
19.
Jpn J Thorac Cardiovasc Surg ; 51(8): 344-8, 2003 Aug.
Article in English | MEDLINE | ID: mdl-12962410

ABSTRACT

OBJECTIVE: This study was planned to investigate if there is any difference in terms of the muscle force between the distal and proximal segments of the latissimus dorsi muscle. SUBJECTS AND METHODS: An inplantable mock circulation system was placed around the latissimus dorsi muscle. The wrapping procedure around the implantable mock circulation was performed by using two different latissimus dorsi muscle segments. In group 1, the very proximal and in group 2, very distal part of the latissimus dorsi were wrapped. The main difference is the blood supply to the distal part of the latissimus dorsi that was interrupted during dissection. During the stimulation period which lasted 120 minutes, the pressure developed in this system and adenosine triphosphate (ATP) levels were measured. RESULTS: The stimulation at 20 Hz did not result in any change in pressure and metabolic data. When it was switched to 43 and 85 Hz, ATP levels decreased with a resultant drop in pressure in group 2. However ATP levels were 15.9 +/- 2.2 micromol/gr and 14.8 +/- 2.5 micromol/gr in group 1, 12.0 +/- 1.4 micromol/gr and 6.1 +/- 1.2 micromol/gr in group 2 at 43 and 85 Hz respectively (p < 0.05) at the end of the 90 minutes. The pressures at the same time interval were 89 +/- 11 and 102 +/- 7 mmHg in group 1, 61 +/- 7 and 65 +/- 8 mmHg in group 2 (p < 0.05). CONCLUSION: In this study, we demonstrated that changes in the distal segment of the latissimus dorsi muscle affects its performance in terms of metabolic and pressure changes during high frequency electrical stimulation at 43 and 85 Hz.


Subject(s)
Myocardial Contraction/physiology , Skeletal Muscle Ventricle/physiology , Adenosine Triphosphate/metabolism , Animals , Blood Pressure/physiology , Coronary Circulation/physiology , Dogs , Electric Stimulation , Models, Animal , Models, Cardiovascular , Time Factors
20.
Cardiovasc Surg ; 10(6): 608-14, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12453696

ABSTRACT

An experimental study was designed to search the effectiveness of retrograde cerebral perfusion which is presently used as cerebral protection method for the surgery of arcus aorta. Twelve dogs were subjected to the study. Six of them were remained in total circulatory arrest at 20 degrees C for 60 min. Retrograde cerebral perfusion was done again at 20 degrees C for 1 h for the other six dogs. Tumor necrosis factor (TNF), P-selectin, Intracellular Adhesion Molecule (ICAM), Creatine Phosphokinase (CPK-BB) and tissue Adenosine triphosphate (ATP) levels were measured, before the cardiopulmonary bypass at 37 degrees C and during perfusion period at 5, 60 min and 4 h. Tissue ATP level for retrograde cerebral perfusion group was 3.99+/-0.7 mcmol/g tissue and 2.86+/-0.1 mcmol/g tissue for total circulatory arrest group at fourth hour (p<0.05). TNF level was significantly higher in total circulatory arrest group than retrograde cerebral perfusion group (p<0.05). The samples taken at fourth hour of reperfusion showed the TNF level was, 162.55+/-13.1 pcg/ml for total circulatory arrest group and this value was 12.5+/-3.4 pcg/ml for retrograde cerebral perfusion group.ICAM (Intracellular Adhesion Molecule) level was higher in total circulatory arrest group (18.75+/-3.6 ng/ml) when compared to retrograde cerebral perfusion group (8.75+/-1.8 ng/ml) (p<0.05). All parameters showed that retrograde cerebral perfusion preserved the brain functions better comparing with total circulatory arrest. The time necessary for aortic surgery may be provided by the retrograde cerebral perfusion technique.


Subject(s)
Brain/metabolism , Cardiopulmonary Bypass/methods , Heart Arrest, Induced , Hypothermia, Induced , Adenosine Triphosphate/metabolism , Animals , Cerebrovascular Circulation , Disease Models, Animal , Dogs , Female , Intercellular Adhesion Molecule-1/blood , Intraoperative Care/methods , Male , P-Selectin/blood , Perfusion , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...